0000849146-23-000206.txt : 20231109 0000849146-23-000206.hdr.sgml : 20231109 20231109170542 ACCESSION NUMBER: 0000849146-23-000206 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20231106 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20231109 DATE AS OF CHANGE: 20231109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lifevantage Corp CENTRAL INDEX KEY: 0000849146 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900224471 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35647 FILM NUMBER: 231393641 BUSINESS ADDRESS: STREET 1: 3300 TRIUMPH BLVD STREET 2: SUITE 700 CITY: LEHI STATE: UT ZIP: 84043 BUSINESS PHONE: 801-432-9000 MAIL ADDRESS: STREET 1: 3300 TRIUMPH BLVD STREET 2: SUITE 700 CITY: LEHI STATE: UT ZIP: 84043 FORMER COMPANY: FORMER CONFORMED NAME: LIFELINE THERAPEUTICS, INC. DATE OF NAME CHANGE: 20041019 FORMER COMPANY: FORMER CONFORMED NAME: YAAK RIVER RESOURCES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: ANDRAPLEX CORP DATE OF NAME CHANGE: 19920406 8-K 1 lfvn-20231106.htm 8-K lfvn-20231106
0000849146false00008491462023-11-062023-11-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 ______________________________
 FORM 8-K
 ______________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 6, 2023
 ______________________________
LIFEVANTAGE CORPORATION
(Exact name of registrant as specified in its charter)
______________________________
Delaware001-3564790-0224471
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)(IRS Employer
Identification No.)
3300 Triumph Blvd., Suite 700
Lehi, Utah 84043
(Address of principal executive offices, including zip code)
(801) 432-9000
(Registrant's telephone number)
_____________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Common Stock, par value $0.0001LFVNThe Nasdaq Stock Market LLC
Title of each classTrading Symbol(s)Name of each exchange on which registered
Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company 
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 






Item 5.07    Submission of Matters to a Vote of Security Holders.

LifeVantage Corporation (the “Company”) held its fiscal year 2024 annual meeting of stockholders on November 6, 2023 (the “Annual Meeting”). The proposals submitted to a vote of the Company’s stockholders at the Annual Meeting are more fully described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission (the “SEC”) on September 22, 2023.

Set forth below are the proposals voted upon at the Annual Meeting, and the estimated preliminary voting results received from First Coast Results, Inc. (the “Inspector of Election”), the independent inspector of election for the Annual Meeting, based on the information available to the Inspector of Election 

Based on the estimated preliminary voting results received from the Inspector of Election and subject to the qualifications set forth herein, of the 12,706,604 shares of the Company’s common stock outstanding as of the record date, 9,257,241 shares, or 72.85%, were represented at the Annual Meeting either in person or by proxy.

These results are preliminary only and are subject to change based on the certification of the final voting results by the Inspector of Election.  The Company will file an amendment to this Current Report on Form 8-K to disclose the final voting results within four business days after receiving the Inspector of Election’s final certified report. At this time, the Company does not know when the Inspector of Election will complete its work and then be able to certify the Annual Meeting vote results. There can be no assurance that the outcome of the final results will be consistent with the outcome of the estimated preliminary vote results indicated on this Form 8-K.

The estimated preliminary tabulation from the Inspector of Election of voting results for the election of directors and other proposals presented at the Annual Meeting were as follows:

Proposal 1 – Election of Directors.

The estimated preliminary votes for each director nominee are set forth below:

Company nominees:
                


For

Withhold

Mr. Michael A. Beindorff

5,829,222

3,345,850

Ms. Erin Brockovich

8,180,791

671,206

Mr. Steven R. Fife

8,236,727

615,271

Mr. Raymond B. Greer

8,170,090

681,907

Ms. Cynthia Latham

8,259,106

592,891

Mr. Darwin K. Lewis

6,081,144

3,093,928

Mr. Garry Mauro

4,614,789

4,560,287







Nominees of Bradley L. Radoff and Sudbury Capital Fund, LP, and certain of their affiliates and other participants in their proxy solicitation:



For

Withhold

Mr. Dayton Judd

4,533,852

 4,601,273

Mr. Michael Lohner

3,290,058

5,845,067

Mr. Bradley L. Radoff

3,064,056

6,071,069


Proposal 2 – Approval, on an Advisory Basis, of a Resolution Approving the Compensation of the Company’s Named Executive Officers.

The estimated preliminary votes for the approval, on an advisory basis, of a resolution approving the compensation of the Company’s named executive officers were as follows:

For
Against
Abstain
5,937,422
2,871,303
366,563






Proposal 3 – Ratification of Selection of Independent Registered Public Accounting Firm.

The estimated preliminary votes for the ratification of the selection of Deloitte & Touche, LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2024 were as follows:

For
Against
Abstain
8,690,892
36,853
529,496

Proposal 4 – Approval of an Amendment to the Company’s 2017 Long-Term Incentive Plan.

The estimated preliminary votes to approve an amendment to the Company’s 2017 Long-Term Incentive Plan were as follows:

For
Against
Abstain
5,893,009
2,812,877
469,403

Proposal 5 – Ratification of the Adoption of the Stockholder Rights Plan between the Company and Computershare Trust Company, N.A., as Rights Agent.

The estimated preliminary votes for the ratification of the adoption of the Stockholder Rights Plan between the Company and Computershare Trust Company, N.A., as Rights Agent, were as follows:

For
Against
Abstain
4,651,264
4,120,670
403,355







SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: November 9, 2023
LIFEVANTAGE CORPORATION

By: /s/ Steven R. Fife
Name: Steven R. Fife
Title: President and Chief Executive Officer











EX-101.SCH 2 lfvn-20231106.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 lfvn-20231106_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Cover [Abstract] Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Type Document Type Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Registrant Name Entity Registrant Name EX-101.PRE 4 lfvn-20231106_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover Page
Nov. 06, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Nov. 06, 2023
Entity Registrant Name LIFEVANTAGE CORP
Entity Central Index Key 0000849146
Amendment Flag false
Entity Incorporation, State or Country Code DE
Entity File Number 001-35647
Entity Tax Identification Number 90-0224471
Entity Address, Address Line One 3300 Triumph Blvd.
Entity Address, Address Line Two Suite 700
Entity Address, City or Town Lehi
Entity Address, State or Province UT
Entity Address, Postal Zip Code 84043
City Area Code 801
Local Phone Number 432-9000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001
Trading Symbol LFVN
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 6 lfvn-20231106_htm.xml IDEA: XBRL DOCUMENT 0000849146 2023-11-06 2023-11-06 0000849146 false 8-K 2023-11-06 LIFEVANTAGE CORP DE 001-35647 90-0224471 3300 Triumph Blvd. Suite 700 Lehi UT 84043 801 432-9000 false false false false Common Stock, par value $0.0001 LFVN NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 M " "TB&E799!YDAD! #/ P $P @ &K$@ 6T-O;G1E C;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" #U$P ! end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 23 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.lifevantage.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports lfvn-20231106.htm lfvn-20231106.xsd lfvn-20231106_lab.xml lfvn-20231106_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "lfvn-20231106.htm": { "nsprefix": "lfvn", "nsuri": "http://www.lifevantage.com/20231106", "dts": { "inline": { "local": [ "lfvn-20231106.htm" ] }, "schema": { "local": [ "lfvn-20231106.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "lfvn-20231106_lab.xml" ] }, "presentationLink": { "local": [ "lfvn-20231106_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://www.lifevantage.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "lfvn-20231106.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "lfvn-20231106.htm", "first": true, "unique": true } } }, "tag": { "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.lifevantage.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 13 0000849146-23-000206-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000849146-23-000206-xbrl.zip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end